abstract gray background

Archives: Resources

PPD | White Paper
EU CGT submission: Are You Ready for New European HTA Regulation?
  • External Link

Our experts discuss the effect of the regulation on companies with cell and gene therapy (CGT) products in the pipeline, five potential challenges, and related opportunities or actions to consider for successful market access.

Read the white paper
PPD | Case Study
Accelerating Asset Transition of a Novel RNAi Therapy from Development to Dossier Submission at PPD’s Athlone GMP Lab
  • External Link

Explore how our GMP lab in Athlone, Ireland helped accelerate product dossier submission

Read More
PPD | Article
Make Your Clinical Trial a Priority in a Busy Landscape
  • External Link

Five key areas to consider from the onset of a trial to make your study a priority in this crowded field.

Read More
PPD | White Paper
Lessons in Cell and Gene Therapies
  • External Link

A primer for understanding these remarkable therapies and their impacts in clinical trial.

Download the white paper